News

[Press release] Cannaport and HAPA pharm sign exclusive cooperation agreement concerning the supply of cannabis flowers and extracts containing cannabinoids to the DACH market Hamburg, 15.03.2022: The Hamburg based distribution and wholesaler company Cannaport GmbH and the internationally operating HAPA pharm GmbH from Dortmund have agreed to an extensive strategic cooperation concerning the supply of …

Cannaport and HAPA pharm sign exclusive cooperation agreement Read More »

HAPA pharm (“HAPA” or the “Company”) operates production facilities in North Macedonia to grow and process medical cannabis for the sale of pharmaceutical cannabis flos and extracts. On May 1st 2020, the Company has successfully received GMP (Good Manufacturing Practice) approval for both facilities.This milestone demonstrates HAPA’s commitment towards stringent quality assurance on premises and …

HAPA pharm receives GMP certification Read More »

HAPA pharm is actively responding to the situation of coronavirus (COVID-19) by following the recommendations of local and international authorities. We have proactively implemented measures that give priority to the health and safety of our employees, customers and partners, including restricted business travel and access to our sites, improved safety and hygiene, and the ability …

COVID-19: A message to our customers, suppliers and partners Read More »

HAPA pharm is an internationally active company focusing on the research, development and marketing of cannabinoid-containing products and drug formulations. The company, which previously operated under the name of HAPA Medical, has established itself as a pharmaceutical producer. With its own cultivation of cannabis plants in Europe, the company stands for the quality of all …

HAPA Medical becomes HAPA pharm Read More »